On May 04, 2026, MED reported earnings of -0.19 USD per share (EPS) for Q1 26, beating the estimate of -0.52 USD, resulting in a 63.82% surprise. Revenue reached 76.04 million, compared to an expected 69.89 million, with a 8.80% difference. The market reacted with a +22.48% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 2 analysts forecast an EPS of -0.65 USD, with revenue projected to reach 73.43 million USD, implying an increase of 242.11% EPS, and decrease of -3.44% in Revenue from the last quarter.